Amanote Research
Register
Sign In
Figure 1: ATF4 as a Pharmacodynamic Marker in Nontransgenic and hAPP-J20 Mice.
doi 10.7717/peerj.2565/fig-1
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Figure 4: ISRIB Does Not Rescue Spatial Learning and Memory Deficits in hAPP-J20 Mice in the Morris Water Maze.
In Vivo Imaging as a Pharmacodynamic Marker
Clinical Cancer Research
Cancer Research
Oncology
Enhanced Cerebral Blood Volume Under Normobaric Hyperoxia in the J20-hAPP Mouse Model of Alzheimer's Disease
Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease
PLoS ONE
Multidisciplinary
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
JAMA Neurology
Neurology
SYTO-13, a Viability Marker as a New Tool to Monitor in Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs
PLoS ONE
Multidisciplinary
Virally Mediated Optogenetic Excitation and Inhibition of Pain in Freely Moving Nontransgenic Mice
Nature Biotechnology
Applied Microbiology
Biotechnology
Biomedical Engineering
Molecular Medicine
Bioengineering
1-Methylxanthine Derived From Caffeine as a Pharmacodynamic Probe of Oxypurinol Effect
British Journal of Clinical Pharmacology
Pharmacology
Figure 1: Single Marker Analysis (SMA) of Additive Effects.
